TPG related stories
All articles and analysis
Opera, Texas Pacific in shoe showdownA lawsuit filed by shoemaker Bruno Magli is indirectly pitting the Bulgari-backed private equity fund Opera against global private equity firm Texas Pacific Group.
- Kayne Anderson closes $550m energy fund
The Los Angeles- and Houston-based investment firm has closed its third energy private equity fund on $550m, more than double its previous fund of $240m.
- Former Clayton pro made partner at TPG
Vincenzo Morelli, a former CD&R executive and latterly a consultant at turnaround specialists Alvarez & Marsal, has joined Texas Pacific Group in London.
- Texas Pacific ups bid for British Vita
The US private equity firm has announced an increased bid after the UK foam rubber maker rebuffed its first offer as undervaluing the company.
- Japanese gold rush ‘finished’
A leading practitioner in the Japanese private equity market has speculated that opportunities for making quick and easy profits in the country are rapidly disappearing.
- Unfair advantages
Hedge funds enjoy partnership structures that give the GPs much better economics on private equity deals. Shhh ... don’t tell their LPs
- Carlyle to launch hedge fund programme
The Carlyle Group will set up its own hedge fund and fund of hedge funds later this year in order to battle growing competition from and meet investor demand for these omnivorous pools of capital.
- Providence, 3i take Crown for $242m
Providence Equity Partners, 3i Group and UK television executive David Elstein have agreed to buy the international business of Crown Media, owner of Hallmark Channel.
- Cypress adds Safety-Kleen CEO as partner
The New York private equity firm has hired industrial executive Ronald Rittenmeyer as a managing director to monitor the firm’s portfolio and lead investments in the industrial sector.
- Leonard Green in $270m exit
Two and a half years after investing $100m into Phoenix Scientific, the Los Angeles private equity firm has agreed to sell the manufacturer of animal pharmaceuticals for approximately $270m in cash and stock to industry player IVAX.